SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation

Zhonghui Xu, Guangdong Ji, Jianbin Shen, Xiaobo Wang, Jiliang Zhou, Li Li

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Transdifferentiation of vascular smooth muscle cells (VSMC) into chondrogenic cells contributes significantly to vascular calcification during the pathogenesis of atherosclerosis. However, the transcriptional mechanisms that control such phenotypic switch remain unclear. This process is characterized by the induction of Sox9 and Col2a1 genes accompanied by the repression of myocardin (Myocd) and SMC differentiation markers such as SM22, SM α-actin and SM-MHC. Here we explore the regulatory role of SOX9, the master regulator for chondrogenesis, in modulating SMC marker gene expression. qRT-PCR and luciferase assays show that over-expression of SOX9 inhibits SMC gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation. Such suppression is independent of the CArG box in the SMC promoters but dependent on myocardin. EMSA assay further shows that SOX9 neither participates in SRF (serum response factor) binding to the CArG box nor interacts with SRF, while co-immunoprecipitation demonstrates an association of SOX9 with myocardin. Conversely, myocardin suppresses SOX9-mediated chondrogenic gene Col2a1 expression. These findings provide the first mechanistic insights into the important regulatory role of SOX9 and myocardin in controlling the transcription program during SMC transdifferentiation into chondrocytes.

Original languageEnglish (US)
Pages (from-to)285-290
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume422
Issue number2
DOIs
StatePublished - Jun 1 2012

Fingerprint

Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Cell Differentiation
Cells
Serum Response Factor
Transcription
Gene expression
Assays
Genes
Vascular Calcification
Gene Expression
Chondrogenesis
Differentiation Antigens
Chondrocytes
Luciferases
Immunoprecipitation
Smooth Muscle
myocardin
Actins

Keywords

  • CArG box
  • Chondrogenesis
  • Col2a1
  • Myocardin
  • Myocd
  • QRT-PCR
  • SM22
  • SOX9
  • SRF
  • Smooth muscle cell differentiation
  • VSMCs

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. / Xu, Zhonghui; Ji, Guangdong; Shen, Jianbin; Wang, Xiaobo; Zhou, Jiliang; Li, Li.

In: Biochemical and Biophysical Research Communications, Vol. 422, No. 2, 01.06.2012, p. 285-290.

Research output: Contribution to journalArticle

Xu, Zhonghui ; Ji, Guangdong ; Shen, Jianbin ; Wang, Xiaobo ; Zhou, Jiliang ; Li, Li. / SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 422, No. 2. pp. 285-290.
@article{d7feb20800b044afa1ef245039be33e4,
title = "SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation",
abstract = "Transdifferentiation of vascular smooth muscle cells (VSMC) into chondrogenic cells contributes significantly to vascular calcification during the pathogenesis of atherosclerosis. However, the transcriptional mechanisms that control such phenotypic switch remain unclear. This process is characterized by the induction of Sox9 and Col2a1 genes accompanied by the repression of myocardin (Myocd) and SMC differentiation markers such as SM22, SM α-actin and SM-MHC. Here we explore the regulatory role of SOX9, the master regulator for chondrogenesis, in modulating SMC marker gene expression. qRT-PCR and luciferase assays show that over-expression of SOX9 inhibits SMC gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation. Such suppression is independent of the CArG box in the SMC promoters but dependent on myocardin. EMSA assay further shows that SOX9 neither participates in SRF (serum response factor) binding to the CArG box nor interacts with SRF, while co-immunoprecipitation demonstrates an association of SOX9 with myocardin. Conversely, myocardin suppresses SOX9-mediated chondrogenic gene Col2a1 expression. These findings provide the first mechanistic insights into the important regulatory role of SOX9 and myocardin in controlling the transcription program during SMC transdifferentiation into chondrocytes.",
keywords = "CArG box, Chondrogenesis, Col2a1, Myocardin, Myocd, QRT-PCR, SM22, SOX9, SRF, Smooth muscle cell differentiation, VSMCs",
author = "Zhonghui Xu and Guangdong Ji and Jianbin Shen and Xiaobo Wang and Jiliang Zhou and Li Li",
year = "2012",
month = "6",
day = "1",
doi = "10.1016/j.bbrc.2012.04.149",
language = "English (US)",
volume = "422",
pages = "285--290",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation

AU - Xu, Zhonghui

AU - Ji, Guangdong

AU - Shen, Jianbin

AU - Wang, Xiaobo

AU - Zhou, Jiliang

AU - Li, Li

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Transdifferentiation of vascular smooth muscle cells (VSMC) into chondrogenic cells contributes significantly to vascular calcification during the pathogenesis of atherosclerosis. However, the transcriptional mechanisms that control such phenotypic switch remain unclear. This process is characterized by the induction of Sox9 and Col2a1 genes accompanied by the repression of myocardin (Myocd) and SMC differentiation markers such as SM22, SM α-actin and SM-MHC. Here we explore the regulatory role of SOX9, the master regulator for chondrogenesis, in modulating SMC marker gene expression. qRT-PCR and luciferase assays show that over-expression of SOX9 inhibits SMC gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation. Such suppression is independent of the CArG box in the SMC promoters but dependent on myocardin. EMSA assay further shows that SOX9 neither participates in SRF (serum response factor) binding to the CArG box nor interacts with SRF, while co-immunoprecipitation demonstrates an association of SOX9 with myocardin. Conversely, myocardin suppresses SOX9-mediated chondrogenic gene Col2a1 expression. These findings provide the first mechanistic insights into the important regulatory role of SOX9 and myocardin in controlling the transcription program during SMC transdifferentiation into chondrocytes.

AB - Transdifferentiation of vascular smooth muscle cells (VSMC) into chondrogenic cells contributes significantly to vascular calcification during the pathogenesis of atherosclerosis. However, the transcriptional mechanisms that control such phenotypic switch remain unclear. This process is characterized by the induction of Sox9 and Col2a1 genes accompanied by the repression of myocardin (Myocd) and SMC differentiation markers such as SM22, SM α-actin and SM-MHC. Here we explore the regulatory role of SOX9, the master regulator for chondrogenesis, in modulating SMC marker gene expression. qRT-PCR and luciferase assays show that over-expression of SOX9 inhibits SMC gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation. Such suppression is independent of the CArG box in the SMC promoters but dependent on myocardin. EMSA assay further shows that SOX9 neither participates in SRF (serum response factor) binding to the CArG box nor interacts with SRF, while co-immunoprecipitation demonstrates an association of SOX9 with myocardin. Conversely, myocardin suppresses SOX9-mediated chondrogenic gene Col2a1 expression. These findings provide the first mechanistic insights into the important regulatory role of SOX9 and myocardin in controlling the transcription program during SMC transdifferentiation into chondrocytes.

KW - CArG box

KW - Chondrogenesis

KW - Col2a1

KW - Myocardin

KW - Myocd

KW - QRT-PCR

KW - SM22

KW - SOX9

KW - SRF

KW - Smooth muscle cell differentiation

KW - VSMCs

UR - http://www.scopus.com/inward/record.url?scp=84861709581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861709581&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.04.149

DO - 10.1016/j.bbrc.2012.04.149

M3 - Article

C2 - 22580282

AN - SCOPUS:84861709581

VL - 422

SP - 285

EP - 290

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -